Abstract 1771
Background
Platelet activation and the release of various growth factors from platelet granules in response to tumor cell profoundly influence tumor biology. Platelet hyperreactivity in cancer patients is a frequently discussed phenomenon; however, cancer patients were also found to have platelet dysfunction. Considerably less is known about exhaustion of platelet kinetics in cancer.
Methods
In this study, we investigated kinetics of intra-platelet growth factors in hepatocellular carcinoma (HCC) recurrence. We prospectively recruited forty patients diagnosed with HCC who were undergoing liver resection. The patients were followed every three months with imagings after the resection. Platelet fractions were separately isolated before and after a month of radical resection of the tumor. Growth factors/cytokines were measured using enzyme-linked immunosorbent assay (ELISA) kits. Follow-up was standardized to two years. HCC recurrence was diagnosed on the basis of imaging.
Results
Fifteen patients developed post-resection HCC recurrence during 2-year follow-up. The concentrations of platelet-alpha granules secreted growth factors [vascular endothelial growth factor-A (VEGF-A), angiopoietin-1(Ang-1)] and dense granules secreted growth factors (serotonin) were significantly depleted in patients with early HCC recurrence. In addition, the post-resection platelet count was also significantly lower in patients with recurrence than those without recurrence. A combined receiver-operating characteristic (ROC) curve generated to determine the cut-off values for these growth factors yielded both specificity and sensitivity of greater than 80%, area under curve (AUC) > 0.8, and P < 0.001. Furthermore, in the binary logistic regression model, VEGF-A was able to independently predict early HCC recurrence (P < 0.05); accordingly, the disease-free interval was substantially worse in accordance with the exhausted intra-platelet growth factors.
Conclusions
We found a qualitative and quantitative platelet crisis, and its prognostic implication in patients with post-resection HCC recurrence. This study provides an avenue to identify the pathophysiological mechanism of the impaired platelet-kinetics and its relevance in cancer biology.
Clinical trial identification
Legal entity responsible for the study
Bibek Aryal.
Funding
Japan Society for the Promotion of Science (JSPS).
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1864 - Tyrosine Kinase Inhibitors and acid-inhibitory drugs : strong concomitant dispensing and drug-drug interaction risk.
Presenter: FRANCOISE GRUDE
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2058 - Intraoperative Detection of Resection Margin by Inhalation of ICG in Lung Cancer Preclinical Study
Presenter: Yu Hua Quan
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4135 - Proteomic-based machine learning computational analysis discovered biomarkers of aberrant vesicle-exosomal trafficking to determine chemotherapeutic responses in breast cancer
Presenter: HanSuk Ryu
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4503 - CARCINOMA OF UNKNOWN ORIGIN: Deep Genomic profile helps to achieve an accurate diagnosis.
Presenter: Amaya Fernandez Díaz
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4820 - Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy.
Presenter: Jenny Lee
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
4174 - A Phase 1 Trial of Vorolanib (X-82), a Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitor, in Patients (pts) with Advanced Solid Tumors
Presenter: Johanna Bendell
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
2759 - Longitudinal analysis of circulating biomarkers to monitor advanced EGFR mutated (EGFR+) non-small cell lung cancer (NSCLC)
Presenter: Pei Ni Ding
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5099 - Genotyping of circulating tumor DNA in biliary tract cancer reveals diagnostic and prognostic information
Presenter: Thomas Ettrich
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5336 - Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC)
Presenter: FEIYU ZHANG
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract
5958 - Association of the rs1883832 variant of CD40 with NSCLC risk and overall survival
Presenter: Fotinos-Ioannis Dimitrakopoulos
Session: Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research
Resources:
Abstract